Daniel C. Maneval
Impact in
- Oncology top 1%
- Pancreatic and Hepatic Oncology Research
- Cancer-related Molecular Pathways
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
- Biotechnology top 0.5%
- Cancer Research and Treatments
Papers in
-
- Fibroblast Growth Factor Research 15
- Glycosylation and Glycoproteins Research 6
- Oncology 26
- HER2/EGFR in Cancer Research 9
- Co-authors
- Loretta L. Nielsen (1 shared paper)H. Michael Shepard (7 shared papers)H. Michael Shepard (15 shared papers)Dennis J. Slamon (4 shared papers)Ping Jiang (12 shared papers)Curtis B. Thompson (13 shared papers)Ken N. Wills (7 shared papers)Michael J. LaBarre (5 shared papers)
- Journals
- Cancer Research (8 papers)Journal of Clinical Oncology (6 papers)Cancer Gene Therapy (4 papers)Physics in Medicine and Biology (3 papers)ESMO Open (3 papers)
- Partner nations
- United StatesGermanyJapan
In The Last Decade
Daniel C. Maneval
72 papers receiving 3.3k citations
Daniel C. Maneval's Hit Papers
Peers
Comparison fields: 5 of 98
- Oncology 1.6k
- Biotechnology 539
- Genetics 852
- Cancer Research 342
- Radiology, Nuclear Medicine and Imaging 479
Countries citing papers authored by Daniel C. Maneval
This map shows the geographic impact of Daniel C. Maneval's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel C. Maneval with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel C. Maneval more than expected).
Fields of papers citing papers by Daniel C. Maneval
This network shows the impact of papers produced by Daniel C. Maneval. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel C. Maneval. The network helps show where Daniel C. Maneval may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel C. Maneval, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer Hit paper breakdown → | 2012 | 852 |
| 2 | 1991 | 254 | |
| 3 | 1994 | 204 | |
| 4 | P53 tumor suppressor gene therapy for cancer. | 1998 | 175 |
| 5 | 2019 | 120 | |
| 6 | 2002 | 106 | |
| 7 | Radiolabeled antibody targeting of the HER-2/neu oncoprotein. | 1992 | 98 |
| 8 | Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein. | 1996 | 98 |
| 9 | Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts. | 1997 | 90 |
| 10 | 2011 | 89 | |
| 11 | Adenoviral-mediated p53 tumor suppressor gene therapy of human ovarian carcinoma. | 1996 | 86 |
| 12 | 1996 | 81 | |
| 13 | p53 gene therapy in a rat model of hepatocellular carcinoma: intra-arterial delivery of a recombinant adenovirus. | 1998 | 79 |
| 14 | 2004 | 76 | |
| 15 | 2018 | 71 | |
| 16 | 2004 | 69 | |
| 17 | Gene therapy for hepatocellular carcinoma: chemosensitivity conferred by adenovirus-mediated transfer of the HSV-1 thymidine kinase gene. | 1995 | 69 |
| 18 | 2017 | 65 | |
| 19 | Relationship between dose rate of [6RS]Leucovorin administration, plasma concentrations of reduced folates, and pools of 5,10-methylenetetrahydrofolates and tetrahydrofolates in human colon adenocarcinoma xenografts. | 1990 | 59 |
| 20 | 2002 | 57 |
About Daniel C. Maneval
Daniel C. Maneval is a scholar working on Molecular Biology, Oncology, Cell Biology, Genetics and Biotechnology, having authored 75 papers that have together received 3.5k indexed citations. Recurring topics across this work include Proteoglycans and glycosaminoglycans research (24 papers), Virus-based gene therapy research (21 papers), Cancer Research and Treatments (19 papers), Fibroblast Growth Factor Research (15 papers), HER2/EGFR in Cancer Research (9 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Cancer, Hypoxia, and Metabolism (7 papers) and Glycosylation and Glycoproteins Research (6 papers). The work is most often cited by research in Oncology (1.6k citations), Biotechnology (539 citations), Genetics (852 citations), Cancer Research (342 citations) and Radiology, Nuclear Medicine and Imaging (479 citations). Daniel C. Maneval has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Loretta L. Nielsen, H. Michael Shepard, H. Michael Shepard, Dennis J. Slamon, Ping Jiang, Curtis B. Thompson, Ken N. Wills, Michael J. LaBarre, Richard J. Gregory and Heather Zecchini. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Cancer Gene Therapy, Physics in Medicine and Biology and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.